| 摘要 |
<p>The current invention relates to the use of D-chiro-inositol in improving insulin sensitivity and glucose metabolism in individuals with abnormal glucose tolerance who do not have Type 2 diabetes. D-chiro-inositol and related oral compositions may be used in treating abnormal glucose tolerance and metabolism and insulin sensitivity in mammals, and thus help prevent the progression to insulin-resistant Type 2 diabetes.</p> |
